State of Weight Loss Drugs
Compound versions of some weight loss drugs to be restricted
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for weight loss, as is permissible by the FDA.
Health on MSN7d
Zepbound Is Now Available in Additional Doses at Lower CostsEli Lilly has reduced the prices of certain Zepbound vials and introduced higher-dose options, making the weight-loss drug ...
Wegovy and Zepbound — are cutting prices to make the medications more affordable for people without insurance.
A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight ...
Novo Nordisk released the results from its late-stage trial of CagriSema on Monday. It showed that patients on the highest dose of the drug lost 15.7% of their weight.
Telehealth firms Teladoc and LifeMD said on Thursday they had signed an agreement to offer Eli Lilly's weight-loss drug ...
Eli Lilly: The U.S. drugmaker’s weight-loss drug Zepbound became the direct rival for Novo Nordisk’s Wegovy, when it was approved by FDA in 2023. The healthcare giant, in July 2023 ...
After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight ...
The Associated Press on MSN7d
Popular weight-loss drugs get cheaper: Novo Nordisk and Eli Lilly cut pricesDanish drugmaker Novo Nordisk said Wednesday that it will drop prices 23% for all doses of Wegovy. The new monthly price of ...
Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.
States across the nation -- including Iowa -- are calling on the Food and Drug Administration (FDA) to take action against ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback